Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299897
Status:
UNKNOWN
Last Update Posted:
2006-10-27
First Post:
2006-03-03
Brief Title:
SP01A The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients
Sponsor:
Samaritan Pharmaceuticals Inc
Organization:
Samaritan Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Human Immunodeficiency Virus |
| HIV Infections |
Keywords:
| Name | View |
|---|---|
| Treatment Experienced | View |
| HIV | View |
| AIDS | View |
| Treatment Resistance | View |
| Treatment Failure | View |
| Mutations | View |
| GP120 | View |
| Entry Inhibitors | View |
| HAART | View |
| antiretroviral | View |
| antiviral | View |
| ARV | View |
| CCR5 | View |
| CXCR4 | View |
| receptors | View |
| intracellular fluid | View |
| lipid rafts | View |
| cholesterol | View |
| chemokine | View |